CDK5 and Alzheimer disease: Given that CDK5 and GSK-3β are strong tau kinases [50], this vicious cycle induced by palmitoyl-L-carnitine may result in a feedback loop of mitochondrial dysfunction and tau hyperphosphorylation, exacerbating AD pathology.